Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SEPN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 41 days ago
Red flags: 0
154 filers reported a long position in SEPN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $234.3M | 7M | Unchanged |
| TRV GP V, LLC | $208.2M | 6.2M | Unchanged |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $148.5M | 4.4M | +0.9% |
| TRV GP VI, LLC | $141M | 4.2M | Unchanged |
| Samsara BioCapital, LLC | $105.5M | 3.1M | Unchanged |
| GOLDMAN SACHS GROUP INC | $102.6M | 3.1M | +5.4% |
| BlackRock, Inc. | $64.7M | 1.9M | +6% |
| Siren, L.L.C. | $63.6M | 1.9M | -5% |
| Avoro Capital Advisors LLC | $44.8M | 1.3M | Unchanged |
| Jupiter Topco LLC | $43.7M | 1.3M | — |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.